Oceania · Markets & Finance · Market Index

Further significant results from SNT-4728 iRBD Phase 2 trial

Published by Market Index · Australia 3 d ago

Read SNT's full ASX announcement titled "Further significant results from SNT-4728 iRBD Phase 2 trial" from 07 Oct 2026, on Market Index.

Read the full article on Market Index Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketindex.com.au)

Also worth reading

Opal Tower declared defect-free eight years after evacuations

The Motley Fool Australia

Telix vs Clinuvel Pharmaceuticals: Which ASX healthcare share deserves your next $1,000 of investment capital?

Part II – Navigating the Tricks of Uranium Investing

Australian Financial Review

Human rights judge wins Nobel Peace Prize

Ten of the most beautiful seaside road trips to do in NSW

Business News (WA)

De Ceglie departs as Perth Bears CEO